Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

Results

Title:	Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
Authors :	Roe, Matthew T.; ...; Dilić, Mirza; ...; Ristić, Arsen D. ; ...; Miličić, Davor; ...; Simić, Dragan V. ; Ivanović, Nikola; Davidović, Goran T. ; Tasić, Nebojša M.; Ašanin, Milika R. ; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Aranđelović, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1576);
Issue Date:	2019
Publication:	CIRCULATION
ISSN:	0009-7322 e1524-4539 Circulation Search Idenfier
Publisher:	Lippincott Williams & Wilkins, Hagerstown
Type:	Article
Collation:	vol. 140 br. 19 str. 1578-1589
DOI:	10.1161/CIRCULATIONAHA.119.042551
WoS-ID:	000494805400011
Scopus-ID:	2-s2.0-85074552197
URI:	https://enauka.gov.rs/handle/123456789/830726
URL:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830944/pdf/cir-140-1578.pdf
Project:	Sanofi Regeneron Pharmaceuticals
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	21a+M21a+

44
SCOPUS^TM

27
OpenCitations

48
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall